Related Experiment Videos
The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies
Vox Sanguinis
|September 2, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Performance of a recombinant fusion protein linking coagulation factor IX with recombinant albumin in one-stage clotting assays.
Journal of thrombosis and haemostasis : JTH·2018
The future of bypassing agents for hemophilia with inhibitors in the era of novel agents.
Journal of thrombosis and haemostasis : JTH·2018
Prophylactic bypassing agent use before and during immune tolerance induction in patients with haemophilia A and inhibitors to FVIII.
Haemophilia : the official journal of the World Federation of Hemophilia·2018
Optimizing bleed prevention throughout the lifespan: Womb to Tomb.
Haemophilia : the official journal of the World Federation of Hemophilia·2018
Expanding the military blood donor pool through non-donor recruitment.
Vox sanguinis·2026
Monitoring of lymphocyte subsets in regular blood donors.
Vox sanguinis·2026